Status:
COMPLETED
Conservative Management of CIN2 Lesions and Biomarkers Evaluation
Lead Sponsor:
Istituto Oncologico Veneto IRCCS
Collaborating Sponsors:
Azienda ULSS 3 Serenissima
Azienda Ulss 6 Euganea
Conditions:
CIN2
Eligibility:
FEMALE
25-45 years
Brief Summary
Prospective study including women aged 25-45 years, adherent to the cervical screening program of four different centers of the Veneto region, with a diagnosis of CIN2 lesion. After enrollment accordi...
Detailed Description
Women aged 25-45 years, adherent to the organized population-based cervical screening program, with a histological diagnosis of CIN2 and fulfilling the inclusion criteria will be invited to participat...
Eligibility Criteria
Inclusion
- age range 25-45 years,
- CIN2 lesions located in the exocervix and completely visible at colposcopy.
Exclusion
- age \>45 years;
- history of previous high-grade lesions;
- squamo-columnar junction not completely visible (type 3);
- cytology with suspect or indicative for invasive lesion;
- lesions exclusively located in the endocervix;
- lesions located in the exocervix but not completely visible;
- pregnancy
Key Trial Info
Start Date :
April 15 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
319 Patients enrolled
Trial Details
Trial ID
NCT04687267
Start Date
April 15 2019
End Date
December 31 2022
Last Update
September 28 2023
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda ULSS 6 Euganea
Padua, PD, Italy
2
Azienda ULSS 2 Marca Trevigiana
Treviso, TV, Italy
3
Azienda ULSS 3 Serenissima
Mestre, VE, Italy
4
Azienda ULSS 9 Scaligera
Verona, VR, Italy